HARVARD BIOSCIENCE, INC. Share-based Payment Arrangement, Accelerated Cost
HARVARD BIOSCIENCE, INC. (HBIO) reported Share-based Payment Arrangement, Accelerated Cost of $100.00 thousand for the 0-month period ending 2015-04-28, per its 10-K filed 2018-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost · last filed 2018-03-16
- 2015-04-28: Share-based Payment Arrangement, Accelerated Cost 0 month $100.00K.
| Period end | Share-based Payment Arrangement, Accelerated Cost 0 month |
|---|---|
| 2015-04-28 | $100.00K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |